piperacillin and tazobactam

Generic: piperacillin sodium,tazobactam sodium

Labeler: fresenius kabi usa, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name piperacillin and tazobactam
Generic Name piperacillin sodium,tazobactam sodium
Labeler fresenius kabi usa, llc
Dosage Form INJECTION, POWDER, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

piperacillin sodium 4 g/20mL, tazobactam sodium .5 g/20mL

Manufacturer
Fresenius Kabi USA, LLC

Identifiers & Regulatory

Product NDC 63323-320
Product ID 63323-320_25123257-e41e-420d-9735-74fc71840b6c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA065523
Listing Expiration 2026-12-31
Marketing Start 2009-10-13

Pharmacologic Class

Classes
penicillin-class antibacterial [epc] penicillins [cs] beta lactamase inhibitor [epc] beta lactamase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63323320
Hyphenated Format 63323-320

Supplemental Identifiers

RxCUI
1659131 1659137 1659149
UNII
UXA545ABTT M98T69Q7HP

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name piperacillin and tazobactam (source: ndc)
Generic Name piperacillin sodium,tazobactam sodium (source: ndc)
Application Number ANDA065523 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 4 g/20mL
  • .5 g/20mL
source: ndc
Packaging
  • 10 VIAL in 1 BOX (63323-320-50) / 20 mL in 1 VIAL
source: ndc

Packages (1)

63323-320-50 10 VIAL in 1 BOX (63323-320-50) / 20 mL in 1 VIAL

Ingredients (2)

piperacillin sodium (4 g/20mL) tazobactam sodium (.5 g/20mL)

Linked Drug Pages (2)

Piperacillin and Tazobactam ndc-match (0.9) Piperacillin and Tazobactam ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "25123257-e41e-420d-9735-74fc71840b6c", "openfda": {"unii": ["UXA545ABTT", "M98T69Q7HP"], "rxcui": ["1659131", "1659137", "1659149"], "spl_set_id": ["fc4d1e35-23eb-4654-8691-ae5bfd50a48a"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 BOX (63323-320-50)  / 20 mL in 1 VIAL", "package_ndc": "63323-320-50", "marketing_start_date": "20091013"}], "brand_name": "Piperacillin and Tazobactam", "product_id": "63323-320_25123257-e41e-420d-9735-74fc71840b6c", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Penicillin-class Antibacterial [EPC]", "Penicillins [CS]", "beta Lactamase Inhibitor [EPC]", "beta Lactamase Inhibitors [MoA]"], "product_ndc": "63323-320", "generic_name": "PIPERACILLIN SODIUM,TAZOBACTAM SODIUM", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Piperacillin and Tazobactam", "active_ingredients": [{"name": "PIPERACILLIN SODIUM", "strength": "4 g/20mL"}, {"name": "TAZOBACTAM SODIUM", "strength": ".5 g/20mL"}], "application_number": "ANDA065523", "marketing_category": "ANDA", "marketing_start_date": "20091013", "listing_expiration_date": "20261231"}